On Wednesday, Hetero Healthcare Ltd launched a generic covid-19 drug favipiravir in India at Rs59 per pill under the brand name Favivir.
The Product will be available at all retail and pharmacies throughout the country from today. Consumers can buy only through a prescription.
Drug Controller General of India(DCGI) has granted this pharmaceutical company for manufacturing and marketing of this anti viral medicine.
Favipiravir is employed within the treatment of mild-to-moderate covid-19, and constitutes 122 pills over a period of fortnight , as per the clinical management protocol for the drugs allowed by the regulator. thereupon dosage, Hetero’s Favivir will cost ₹7,198 for the whole course.
Hetero’s Favivir is that the second drug developed by Hetero for the treatment of Covid-19. Last month, the firm had launched Covifor, a licensed generic of Gilead Sciences Inc’s novel drug Remdesivir, for the treatment of severe covid-19 patients.
The drug are going to be being manufactured at its formulation facility in Hyderabad, which has been approved by stringent global regulatory authorities like US FDA and therefore the EU, among others.